Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
British Journal of Dermatology
Published September 26, 2026
Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using...
September 26, 2026
Medspoke
Medspoke
British Journal of Dermatology
Published September 26, 2026
00:00
--:--
Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phas...
September 26, 2026
Share
Efficacy and Safety of Risankizumab in Paediatric Patients With Psoriasis in the OptIMMize-1 Phase III Study.
https://www.medspoke.co/channel_journal?id=875&tap_id=14472
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
RMD Open
Published September 25, 2026
Risk of new primary cancer, locoregional progression or metastasis associated with bDMARDs and ts...
September 26, 2026
Why are you reporting this TALK?
